EAST ST. LOUIS — A woman is suing Sanofi S.A., Aventis Pharma S.A., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, pharmaceutical companies, citing alleged design defect, negligence, product liability and insufficient measures taken to prevent injuries.
Mary Renee Chase filed a complaint on May 27 in the U.S. District Court for the Southern District of Illinois against the defendants, alleging that they failed to provide a listing of potential harmful effects of their product on its label.
According to the complaint, the plaintiff alleges that, between January 2013 and February 2013, she was diagnosed with permanent alopecia as a result of undergoing chemotherapy with Taxotere. The plaintiff holds Sanofi S.A., Aventis Pharma S.A., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC responsible because the defendants allegedly failed to inform or disclose to their consumers the potential harm Taxotere can inflict.
The plaintiff requests a trial by jury and seeks general damages, all medical expenses, punitive and exemplary damages, interest, restitution, disgorgement of profits, court costs and any further relief as this court sees fit. She is represented by Trent B. Miracle of Simmons Hanly Conroy in Alton and Timothy J. Becker, Michael K. Johnson and Peter C. Snowdon of Johnson Becker, PLLC in Minneapolis.
U.S. District Court for the Southern District of Illinois case number 3:16-cv-00588-SMY-PMF